These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35952593)

  • 41. Alpha-synuclein, lipids and Parkinson's disease.
    Ruipérez V; Darios F; Davletov B
    Prog Lipid Res; 2010 Oct; 49(4):420-8. PubMed ID: 20580911
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Membrane interactions of oligomeric alpha-synuclein: potential role in Parkinson's disease.
    van Rooijen BD; Claessens MM; Subramaniam V
    Curr Protein Pept Sci; 2010 Aug; 11(5):334-42. PubMed ID: 20423294
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acrolein and Copper as Competitive Effectors of α-Synuclein.
    Falcone E; Ahmed IMM; Oliveri V; Bellia F; Vileno B; El Khoury Y; Hellwig P; Faller P; Vecchio G
    Chemistry; 2020 Feb; 26(8):1871-1879. PubMed ID: 31804737
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote α-synuclein aggregation.
    Galvagnion C; Marlet FR; Cerri S; Schapira AHV; Blandini F; Di Monte DA
    Brain; 2022 Apr; 145(3):1038-1051. PubMed ID: 35362022
    [TBL] [Abstract][Full Text] [Related]  

  • 45. α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis.
    Mehra S; Sahay S; Maji SK
    Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):890-908. PubMed ID: 30853581
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Calcium promotes α-synuclein liquid-liquid phase separation to accelerate amyloid aggregation.
    Huang S; Xu B; Liu Y
    Biochem Biophys Res Commun; 2022 May; 603():13-20. PubMed ID: 35276458
    [TBL] [Abstract][Full Text] [Related]  

  • 47. α-Synuclein and Lewy pathology in Parkinson's disease.
    Kalia LV; Kalia SK
    Curr Opin Neurol; 2015 Aug; 28(4):375-81. PubMed ID: 26110807
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ganglioside GM3 stimulates lipid-protein co-assembly in α-synuclein amyloid formation.
    Fridolf S; Pham QD; Pallbo J; Bernfur K; Linse S; Topgaard D; Sparr E
    Biophys Chem; 2023 Feb; 293():106934. PubMed ID: 36493587
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein.
    Li J; Uversky VN; Fink AL
    Biochemistry; 2001 Sep; 40(38):11604-13. PubMed ID: 11560511
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Coordination of copper to the membrane-bound form of α-synuclein.
    Dudzik CG; Walter ED; Abrams BS; Jurica MS; Millhauser GL
    Biochemistry; 2013 Jan; 52(1):53-60. PubMed ID: 23252394
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A revised picture of the Cu(II)-α-synuclein complex: the role of N-terminal acetylation.
    Moriarty GM; Minetti CA; Remeta DP; Baum J
    Biochemistry; 2014 May; 53(17):2815-7. PubMed ID: 24739028
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Redox reactions of the α-synuclein-Cu(2+) complex and their effects on neuronal cell viability.
    Wang C; Liu L; Zhang L; Peng Y; Zhou F
    Biochemistry; 2010 Sep; 49(37):8134-42. PubMed ID: 20701279
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synuclein Family Members Prevent Membrane Damage by Counteracting α-Synuclein Aggregation.
    Scheibe C; Karreman C; Schildknecht S; Leist M; Hauser K
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439733
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of Lipid Membranes on α-Synuclein Aggregation.
    Kurochka AS; Yushchenko DA; Bouř P; Shvadchak VV
    ACS Chem Neurosci; 2021 Mar; 12(5):825-830. PubMed ID: 33566579
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of the metal status of natively purified alpha-synuclein from human blood, brain tissue, or recombinant sources using size exclusion ICP-MS reveals no significant binding of Cu, Fe or Zn.
    Lothian A; Lago L; Mukherjee S; Connor AR; Fowler C; McLean CA; Horne M; Masters CL; Cappai R; Roberts BR
    Metallomics; 2019 Jan; 11(1):128-140. PubMed ID: 30465671
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alpha-Synuclein Nitration and Its Implications in Parkinson's Disease.
    He Y; Yu Z; Chen S
    ACS Chem Neurosci; 2019 Feb; 10(2):777-782. PubMed ID: 30183251
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Understanding the Inhibitory and Antioxidant Effects of Pyrroloquinoline Quinone (PQQ) on Copper(II)-Induced α-Synuclein-119 Aggregation.
    Li S; Raja A; Noroozifar M; Kerman K
    ACS Chem Neurosci; 2022 Apr; 13(8):1178-1186. PubMed ID: 35413176
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Computational investigation of copper-mediated conformational changes in α-synuclein dimer.
    Savva L; Platts JA
    Phys Chem Chem Phys; 2024 Jan; 26(4):2926-2935. PubMed ID: 38193190
    [TBL] [Abstract][Full Text] [Related]  

  • 59. α-Synuclein: membrane interactions and toxicity in Parkinson's disease.
    Auluck PK; Caraveo G; Lindquist S
    Annu Rev Cell Dev Biol; 2010; 26():211-33. PubMed ID: 20500090
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Α-synuclein misfolding and Parkinson's disease.
    Breydo L; Wu JW; Uversky VN
    Biochim Biophys Acta; 2012 Feb; 1822(2):261-85. PubMed ID: 22024360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.